TWD 75.9
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.12 Billion TWD | 50.47% |
2022 | 745.4 Million TWD | 4.44% |
2021 | 713.7 Million TWD | 8.43% |
2020 | 658.22 Million TWD | 24.65% |
2019 | 528.07 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 175.66 Million TWD | -50.45% |
2024 Q2 | 207.75 Million TWD | 18.27% |
2023 Q4 | 354.52 Million TWD | 24.49% |
2023 FY | 1.12 Billion TWD | 50.47% |
2023 Q3 | 284.77 Million TWD | -7.61% |
2023 Q2 | 308.22 Million TWD | 77.06% |
2023 Q1 | 174.07 Million TWD | -76.52% |
2022 FY | 745.4 Million TWD | 4.44% |
2022 Q4 | 741.44 Million TWD | 0.0% |
2021 FY | 713.7 Million TWD | 8.43% |
2020 FY | 658.22 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Allied Biotech Corporation | 157.72 Million TWD | -611.11% |
GeneFerm Biotechnology Co., Ltd. | 132.78 Million TWD | -744.666% |
Easywell Biomedicals, Inc. | 333.45 Million TWD | -236.356% |
TTY Biopharm Company Limited | 1.91 Billion TWD | 41.328% |
Synmosa Biopharma Corporation | 1.49 Billion TWD | 25.207% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 47.765% |
Center Laboratories, Inc. | 697.35 Million TWD | -60.835% |
Tien Liang BioTech Co., Ltd. | 267.27 Million TWD | -319.644% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | -139.317% |
InnoPharmax Inc. | 82.29 Million TWD | -1262.883% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | -358.482% |
Excelsior Biopharma Inc. | 388.05 Million TWD | -189.028% |
DV Biomed Co., Ltd. | 575.24 Million TWD | -94.978% |
Handa Pharmaceuticals, Inc. | 399.14 Million TWD | -180.997% |
UniPharma Co., Ltd. | 78.32 Million TWD | -1332.053% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | -182.565% |
Alar Pharmaceuticals Inc. | 83.74 Million TWD | -1239.301% |
Winston Medical Supply Co., Ltd. | 151.49 Million TWD | -640.343% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -189359.122% |
Bioray Biotech Co., Ltd | 96.98 Million TWD | -1056.501% |
TSH Biopharm Corporation Limited | 336.26 Million TWD | -233.542% |